Anavex Life Sciences Corp (AVXL)

[powerwalker]

nidan, I appreciate your thoughts and agree with them.

I think we'll get data on the 21 month original trial/9 month new trial sometime in September/October at a conference, i.e., a press conference in which the FDA legitimizes 2-73 via its new regs, which rewards the safety factor before efficacy.

The upcoming trials (Rett, PArkinson's and Alzheimer's) will be conducted to prove efficacy and, therefore, to strengthen the case for 2-73 with the PK/PD establishing the parameters for selecting those participants with the strongest upside potential, yet allowing 2-73 to be prescribed to the general public ... Anavex NOW.

As an advocate of 2-73, I believe the 9 month data of those switching from combo to mono in Australia will establish its efficacy that regardless of participant numbers will prove to be indisputable ...

"IT WORKS!"

Also ... "OH, forget it" ... I was going to sound too political.